Biotech

All Articles

Vertex, beaten by AATD once again, goes down 2 properties on throw away pile

.Tip's effort to handle an unusual hereditary disease has attacked an additional obstacle. The biote...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of personnel

.Vir Medical's second-quarter profits document wasn't except big information. The company welcomed a...

Galapagos stops CAR-T tissue treatment hearing over Parkinsonism scenario

.Galapagos has stopped application in a trial of a BCMA-directed CAR-T tissue treatment, pushing the...

James Wilson leaving behind Penn to introduce 2 brand new biotechs

.After greater than three decades, gene treatment trailblazer James Wilson M.D., Ph.D., is leaving b...

3 biotechs attempt to beat the summer warm by shedding staff

.As biotechs try to turn a fresh page in August, at the very least 3 providers have actually lost te...

venBio elevates $528M for 5th lifestyle sciences VC fund

.Veteran venture capital company venBio has actually raised an additional half a billion bucks to ac...

Otsuka pays out $800M for Jnana and its clinical-stage PKU medication

.Otsuka Drug has actually grabbed Boston-based Jnana Therapies for $800 thousand so the Japanese bio...

FibroGen lays off 75% of US staff as possession flunks 2 more trials

.FibroGen is radically restructuring its own organization, giving up 75% of its own U.S. team and al...

Tracon winds down full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has chosen to wane functions weeks after an injectable immune system checkpo...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...